In conclusion, our findings reveal that legumain is involved in the pathogenesis of AKI by participating in chaperone-mediated autophagy of critical ferroptosis-protective factor GPX4, suggesting legumain a therapeutic target and early diagnostic marker for AKI. The gene discussed is LGMN; the disease is acute kidney injury.